Terminology Service < Semantic Lookup Platform

All terms in NCIT

Label	Id	Description
Fibrosarcoma	NCIT_C3043	[A malignant mesenchymal fibroblastic neoplasm affecting the soft tissue and bone.]
Medicated Swab Dosage Form	NCIT_C68955	[A solid composed of active and/or inert ingredient(s) on a small piece of absorbent material attached to one end of a stick.]
Stage II Cervical Cancer AJCC v6	NCIT_C7803	[Stage II includes: II (T2, N0, M0); IIA (T2a, N0, M0); IIB (T2b, N0, M0). T2: Cervical carcinoma invades beyond uterus but not to pelvic wall or to lower third of vagina. T2a: Tumor without parametrial invasion. T2b: Tumor with parametrial invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.)]
Cervical Cancer by AJCC v6 Stage	NCIT_C90493	[A term that refers to the staging of cervical cancer according to the American Joint Committee on Cancer, 6th edition.]
Medicated Pad Dosage Form	NCIT_C68957	[A solid composed of active and/or inert ingredient(s) in a soft, non-adhesive and absorbent piece of fabric or other material.]
Recurrent Cervical Carcinoma	NCIT_C7804	[The reemergence of cervical carcinoma after a period of remission.]
Medicated Film Dosage Form	NCIT_C68958	[A film composed of active and/or inert ingredient(s).]
Film Dosage Form	NCIT_C42932	[A thin layer of water soluble or insoluble polymer intended to coat the site of administration.]
Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma	NCIT_C7805	[The reemergence of primary cutaneous T-cell non-Hodgkin lymphoma after a period of remission.]
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma	NCIT_C3467	[A T-cell non-Hodgkin lymphoma arising from the skin. Representative examples include mycosis fungoides and primary cutaneous anaplastic large cell lymphoma.]
Recurrent Mature T- Cell and NK-Cell Non-Hodgkin Lymphoma	NCIT_C8688	[The reemergence of mature T-cell and NK-cell non-Hodgkin lymphoma after a period of remission.]
Recurrent Primary Cutaneous Lymphoma	NCIT_C142876	[The reemergence of primary cutaneous lymphoma after a period of remission.]
Inhaler Kit	NCIT_C68959
Localized Ewing Sarcoma	NCIT_C7806	[Ewing sarcoma which has not spread from its initial site.]
Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor	NCIT_C27901	[A small round cell tumor with or without neural differentiation which is confined to a specific site without evidence of spread to another anatomic site.]
Infusion Bottle	NCIT_C68960
Bottle	NCIT_C43169	[A vessel with a narrow neck designed to accept a specific closure.]
Pipette	NCIT_C68961
Therapeutic Angiotensin-(1-7)	NCIT_C68962	[A synthetic heptapeptide identical to endogenous angiotensin-(1-7) with vasodilator and antiproliferative activities. Therapeutic angiotensin 1-7 may inhibit cyclooxygenase 2 (COX-2) and the production of proinflammatory prostaglandins and may activate the angiotensin-(1-7) receptor Mas, resulting in diminished tumor cell proliferation. Activation of the angiotensin-(1-7) receptor Mas, a G-protein coupled, seven transmembrane protein, may down-regulate the phosphorylation and activation of Erk1 and Erk2 in the Erk1/Erk2 MAPK signaling pathway. In the renin-angiotensin system, the vasodilating activity of angiotensin- (1-7), hydrolysed from angiotensin II by the type I transmembrane metallopeptidase and carboxypeptidase angiotensin converting enzyme 2 (ACE2) in vivo, counteracts the vasoconstricting activity of angiotensin II.]
MRVI1 wt Allele	NCIT_C54322	[Human MRVI1 wild type allele, which is located in the vicinity of 11p15 and is approximately 118 kb in length. This allele, which encodes murine retrovirus integration site 1 homolog protein, plays a role in the regulation of both nitric oxide signaling and calcium release.]